Officials of three Fortune 500 companies take part in panel discussion in Carey’s Distinguished Speakers Series.
New research published in Health Affairs shows that the amount of charity care provided by government and nonprofit hospitals does not meet the obligation implied by their advantageous tax status.
In a commentary for The New England Journal of Medicine, Bloomberg Distinguished Professor Daniel Polsky writes about the impact of private-equity investment on the health care industry.
Using the business and health care expertise developed during her MBA, Katherine Hudak is on the team leading equitable global access to COVID-19 vaccines.
The Carey economics professor joins a group of leading academic researchers and health care professionals working under the banner of the National Academies of Sciences, Engineering, and Medicine.
Matthew Kahn, a Bloomberg Distinguished Professor at the Carey Business School, examines urgent issues in pair of volumes appearing a month apart.
Experts discuss a wide range of conditions for the safe and prompt distribution of the inoculations.
Dr. Denice Cora-Bramble’s (MBA ‘03) career was an uphill battle. As a woman of color, she often had to work twice as hard to reach the top — ultimately being named chief medical officer at Children’s National Hospital. She credits Johns Hopkins for giving...
Stephanie Linnartz, Group President – Consumer Operations, Technology & Emerging Businesses at Marriott International, shares key insights on how she helped to strengthen Marriott before, during, and after the pandemic, as well as major lessons in...
Associate Professor Tinglong Dai of the Johns Hopkins Carey Business School, an expert in health care industry operations management and business analytics, examines the daunting process of administering a COVID-19 vaccine globally.
Christoph Lengauer (MBA ’01) has been closely involved in the funding and development of a cancer-detection blood test.
Dr. Anthony Fauci delivered a keynote address exploring the pandemic response options after the production of a vaccine.